Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
Use this AMLX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AMLX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AMLX SEC filings page. Lician reads the product cache first so this HTML stays unique to Amylyx Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full AMLX income, balance, and cash tables.